{
    "2018-06-19": [
        [
            {
                "time": "",
                "original_text": "恒瑞 1 类新药启动临床，研发已投入千万",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "新药",
                        "临床",
                        "研发",
                        "投入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "糖尿病市场变局！2018国产竞争者VS外企领先者，谁会赢？",
                "features": {
                    "keywords": [
                        "糖尿病",
                        "市场",
                        "国产",
                        "外企",
                        "竞争"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大批获欧美批文药品，报一致性评价",
                "features": {
                    "keywords": [
                        "药品",
                        "欧美",
                        "批文",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "PD-1抗体药物年销320亿重磅药物，中国上市了",
                "features": {
                    "keywords": [
                        "PD-1",
                        "抗体药物",
                        "重磅",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中长期向上趋势不变 医药生物存“升”机",
                "features": {
                    "keywords": [
                        "中长期",
                        "向上趋势",
                        "医药生物",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "年销百亿的重磅肿瘤药物，在中国上市！",
                "features": {
                    "keywords": [
                        "年销百亿",
                        "肿瘤药物",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沉默、崩溃、骂战、坚持——磨底阶段股民百态",
                "features": {
                    "keywords": [
                        "沉默",
                        "崩溃",
                        "骂战",
                        "坚持",
                        "磨底阶段",
                        "股民"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "3000点保卫战打响 白酒、医药等防御性标的成“主战场”",
                "features": {
                    "keywords": [
                        "3000点",
                        "保卫战",
                        "白酒",
                        "医药",
                        "防御性",
                        "主战场"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "机构集中推荐119只个股 医药生物等三行业存“升”机",
                "features": {
                    "keywords": [
                        "机构",
                        "推荐",
                        "个股",
                        "医药生物",
                        "行业",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报: pd-1单抗药物实现国内首上市",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "pd-1",
                        "单抗药物",
                        "国内首上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}